Antiviral (RNA) activity of selected amaryllidaceae isoquinoline constituents and synthesis of related substances

Journal of Natural Products

Volumn 55, Issue 11, 1992, Pages 1569-1581

  Gabrielsen, Bjarne ^a   Monath, Thomas P ^a   Huggins, John W ^a   Kefauver, Deborah F ^a   Pettit, George R ^b   Groszek, Grazyna ^b   Hollingshead, Melinda ^c   Kirsi, Jorma J ^c   Shannon, William M ^c   Schubert, Ernst M ^d   Dare, Jay ^d   Ugarkar, Bheema ^d   Ussery, Michael A ^e   Phelan, Michael J ^e  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

^d Pharm Eco Laboratories ^*  (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOQUINOLINE DERIVATIVE; LYCORICIDINE; LYCORINE; NARCICLASINE; PANCRATISTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BUNYAVIRUS; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SYNTHESIS; FLAVIVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PROPHYLAXIS; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE; VACCINIA VIRUS; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;

ANIMAL; ANTIVIRAL AGENTS; ENCEPHALITIS, JAPANESE; ISOQUINOLINES; MICE; MICE, INBRED C57BL; PLANTS, MEDICINAL; PLAQUE ASSAY; RNA VIRUSES; SUPPORT, U.S. GOV'T, NON-P.H.S.; VIRUSES;

ALPHAVIRUS; AMARYLLIDACEAE; ANIMALIA; DENGUE VIRUS GROUP; EQUIDAE; FLAVIVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; JAPANESE ENCEPHALITIS VIRUS; LENTIVIRUS; MURINAE; ORTHOBUNYAVIRUS; RIFT VALLEY FEVER VIRUS; SANDFLY FEVER SICILIAN VIRUS; VACCINIA; VACCINIA VIRUS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

EID: 0026498292     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np50089a003     Document Type: Article

References (56)

1. G.R. Pettit, C.L. Herald, and C.R. Smith, “Biosynthetic Products for Cancer Chemotherapy,” Elsevier Scientific, Amsterdam, 1989, Vol. 6.
2. S.F. Martin, in: “The Alkaloids.” Ed. by A. Brossi, Academic Press, New York, 1987, Vol. 30, pp. 251-376, and references therein.
3. B.W. Fox, Tram. R. Soc. Trop. Med. Hyg., 85, 22 (1991).
4. G. Ceriotti, Nature, 213, 595 (1967).
5. G.R. Pettit, V. Gaddamidi, and G.M. Cragg, J. Nat. Prod., 47, 1018 (1984).
6. G.R. Pettit, V. Gaddamidi, G.M. Cragg, D.L. Herald, and Y. Sagawa, J. Chem. Soc., Chem. Commun., 1693(1984).
7. G.R. Pettit, V. Gaddamidi, D.L. Herald, S.B. Singh, G.M. Cragg, J.M. Schmidt, F.E. Boettner, M. Williams and Y. Sagawa, J. Nat. Prod., 49, 995 (1986).
8. S. Danishefsky and J.Y. Lee, J. Am. Chem. Soc., 111, 4829 (1989).
9. R.C. Thompson and J.A. Kallmerten, in: “Abstracts.” Div. of Org. Chem., 199th A.C.S. Meeting, Boston, Mass., April 22-27, 1990, Abstr. 234.
10. G.R. Pettit, G.M. Cragg, S.B. Singh, J.A. Duke, and D.L. Doubek, J. Nat. Prod., 53, 176 (1990).
11. M.I. Suffness and G.A. Cordell, in: “The Alkaloids.” Ed. by A. Brossi, Academic Press, New York, 1985, Vol. 25, pp. 198-212.
12. E. Furusawa, H. Irie, D. Combs, and W. Wildman, Chemotherapy, 26, 36 (1980).
13. E. Furusawa, S. Furusawa, J. Lee, and S. Patanavanich, Chemotherapy, 24, 259 (1978).
14. A. Baez and D. Vasquez, Biochim. Biophys. Acta, 518, 95 (1978).
15. A. Jimenez, A. Santos, G. Alonso, and D. Vasquez, Biochim. Biophys. Acta, 425, 342 (1976).
16. I. Ieven, A.J. Vlietinck, D.A. Vanden Berghe, J. Totte, R. Dommisse, E. Esmans, and F. Alderweireldt,J. Nat. Prod., 45, 564 (1982).
17. R. Vrijsen, D. Vanden Berghe, A. Vlietinck, and A. Boeye, J. Biol. Chem., 261, 505 (1986).
18. R.K.-Y. Zee-Cheng, S.-J. Yan, and C.C. Cheng, J. Med. Chem., 21, 199 (1978).
19. T.S. Papas, L. Sandhaus, M.A. Chirigos, and E. Furusawa, Biochem. Biophys. Res. Commun., 52, 88 (1973).
20. E. Furusawa and W. Cutting, Ann. N. Y. Acad. Sci., 173, 668 (1970).
21. E. Furusawa, S. Furusawa, S. Morimoto, and W. Cutting, Proc. Soc. Exp. Biol. Med., 136, 1168 (1971).
22. T.H. Kinstle, W.C. Wildman, and C.L. Brown, Tetrahedron Lett., 4659(1966).
23. J.W. Huggins, in: “Antiviral Agents and Viral Diseases of Man.” Ed. by G.J. Galasso, R.J. Whitley, and T.C. Merigan, Raven Press, New York, 3rd ed., 1990, pp. 691-726.
24. T.P. Monath, N. Engl. J. Med., 319, 641 (1988).
25. A.D.T. Barrett, Current Opinion In Infectious Diseases, 3, 374 (1990).
26. C.H. Hoke, A. Nisalak, N. Sangawhipa, S. Jatansen, T. Laorakapongse, B.L. Innis, S. Kotchasenee, J.B. Gingrich, J. Latendresse, K. Fukai, and D.S. Burke, N. Engl. J. Med., 319, 608 (1988).
27. D.G. Harrington, D.E. Hilmas, M.R. Elwell, R.E. Whitmire, and E.L. Stephen, Am. J. Trop. Med. Hyg., 26, 1191(1977).
28. F.J. Malinoski, S.E. Hasty, M.A. Ussery, and J.M. Dalrymple, Antiviral Res., 13, 139 (1990).
29. R.W. Sidwell, G.R. Revankar, and R.K. Robins, in: “Vital Chemotherapy.” Ed. by D. Shugar, Pergamon Press, New York, 1985, Vol. 2, pp. 49-108.
30. J.W. Huggins, Rev. Infect. Dis., 11, 5750(1989).
31. F. Piozzi, C. Fuganti, R. Mondelli, and G. Ceriotti, Tetrahedron, 24, 1119(1968).
32. H. Paulsen and M. Stubbe, Tetrahedron Lett., 23, 3171(1982).
33. H. Paulsen and M. Stubbe, Liebigs Ann. Chem., 535 (1983).
34. T. Sano, N. Kashiwaba, J. Toda, Y. Tsuda, and H. Irie, Heterocycles, 14, 1097 (1980) and references therein.
35. S.F. Martin and C. Tu, J. Org. Chem., 46, 3763(1981).
36. S.F. Martin, C. Tu, M. Kimuta, and S. Simonsen, J. Org. Chem., 47, 3634 (1982).
37. Y. Tsuda, T. Sano, J. Taga, K. Isobe, J. Toda, S. Takagi, M. Yamaki, M. Murata, H. Irie, and H. Tanaka, J. Chem. Soc., Perkin Trans. I, 1358 (1979).
38. O. Moller, E.-M. Steinberg, and K. Torssell, Acta Chem. Stand., Ser. B., 32, 98 (1978).
39. K. Krohn and A. Mondon, Chem. Ber., 109, 855 (1976).
40. K. Isobe, J.I. Taga, and Y. Tsuda, Heterocycles, 9, 625 (1978).
41. T. Okamoto, Y. Torii, and Y. Isogai, Chem. Pharm. Bull., 16, 1860 (1968).
42. R. Boeckman Jr., S. Goldstein, and M. Walters, J. Am. Chem. Soc., 110, 8250(1988).
43. G. Stork and D.J. Morgans Jr., J. Am. Chem. Soc., 101, 7110(1979).
44. S. Ohta and K. Kimoto, Chem. Pharm. Bull., 24, 2977 (1976).
45. B.G. Ugarkar, J. DaRe, and E.M. Schubert, Synthesis, 715 (1987).
46. V. VanRheenen, R.C. Kelly, and D.Y. Cha, Tetrahedron Lett., 1973 (1976).
47. A. Mondon and K. Krohn, Chem. Ber., 108, 445 (1975).
48. W.L. Brown and T. Durst, in: “Abstracts.” Division of Organic Chemistry, The Third Chemical Congress of North America, Toronto, Canada, June 5-10, 1988, Abstract 124.
49. K. Upadhya, J. DaRe, E.M. Schubert, G.N. Chmurny, and B. Gabrielsen, Nucleosides Nucleotides, 9, 649(1990).
50. J.J. Kirsi, J.A. North, P.A. McKernan, B.K. Murray, P.G. Canonico, J.W. Huggins, P.C. Srivastava, and R.K. Robins, Antimicrob. Agents Chemother., 24, 353 (1983).
51. J.J. Kirsi, P.A. McKernan, N.J. Burns III, J.A. North, B.K. Murray, and R.K. Robins, Antimicrob. Agents Chemother., 26, 466 (1984).
52. R.W. Sidwell and J.H. Huffman, Appl. Microbiol., 22, 797 (1971).
53. R. Pauwels, J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijn, J. Desmyter, and E. De-Clercq,J. Virol. Methods, 20, 309(1988).
54. O.S. Weislow, R. Kiser, D.L. Fine, J. Bade, R.H. Shoemaker, and M.R. Boyd, J. Natl. Cancer Inst., 81, 577(1989).
55. M.A. Ussery, S.E. Asian J. Trop. Med. Publ. Health, 12, 436 (1981).
56. J.W. Huggins, R.K. Robins, and P.G. Canonico, Antimicrob. Agents Chemother., 26, 476 (1984).